Sellam Alexandre, Coscas Florence, Lumbroso-Le Rouic Livia, Dendale Rémi, Lupidi Marco, Coscas Gabriel, Desjardins Laurence, Cassoux Nathalie
Department of Ocular Oncology, Institut Curie, Paris, France; University Paris V Descartes, Paris, France.
Centre Ophtalmologique de l'Odéon, Paris, France; Department of Ophthalmology, Centre Hospitalier Intercommunal, Créteil, France.
Am J Ophthalmol. 2017 Sep;181:12-19. doi: 10.1016/j.ajo.2017.06.008. Epub 2017 Jun 21.
To describe the macular features of patients treated with proton beam therapy for choroidal melanoma (CM), using optical coherence tomography angiography (OCTA).
Retrospective case-control study.
This study included patients treated with proton beam radiotherapy (PBR) for a small CM. Only patients who had received 100% of the dose of 60 Gy external beam radiation to the macular area were included in the analysis. All the patients had undergone a full ophthalmologic examination, including visual acuity, optical coherence tomography B-scan, and OCTA. Qualitative and quantitative vascular features of the retinal plexus and the choriocapillaris were analyzed on OCTA and compared with those in healthy subjects matched on age and sex.
Thirty-seven patients had undergone an OCTA after PBR for a small CM. Seventeen patients (9 men and 8 women) were included. The mean age of the patients was 56.6 years (range, 28-86). At presentation, the mean tumor thickness was 3.39 mm (range, 1.3-7.0 mm). The mean follow-up duration was 35.8 months (range, 11-72 months). Thirteen patients (76.5%) had a clinical radiation maculopathy; 8 patients (47.1%) had macular cysts on OCT-B scan. All patients (100%) had abnormalities on OCTA. Some "signal void" spots were detected at the level of the choriocapillaris in 15 patients (88.2%). The mean vascular density (regarding the full retina) was significantly lower in the patients treated with PBR than in healthy subjects (P < .0001).
Patients treated with PBR for CM (with 100% of the dose given to the macula) present major changes at both plexuses but also a vascular rarefaction of the choriocapillaris.
使用光学相干断层扫描血管造影(OCTA)描述接受质子束治疗脉络膜黑色素瘤(CM)患者的黄斑特征。
回顾性病例对照研究。
本研究纳入了因小型CM接受质子束放疗(PBR)的患者。分析中仅纳入了黄斑区接受60 Gy外照射全剂量的患者。所有患者均接受了全面的眼科检查,包括视力、光学相干断层扫描B扫描和OCTA。在OCTA上分析视网膜神经纤维层和脉络膜毛细血管的定性和定量血管特征,并与年龄和性别匹配的健康受试者进行比较。
37例患者在小型CM接受PBR后进行了OCTA检查。纳入17例患者(9例男性和8例女性)。患者的平均年龄为56.6岁(范围28 - 86岁)。就诊时,平均肿瘤厚度为3.39 mm(范围1.3 - 7.0 mm)。平均随访时间为35.8个月(范围11 - 72个月)。13例患者(76.5%)有临床放射性黄斑病变;光学相干断层扫描B扫描显示8例患者(47.1%)有黄斑囊肿。所有患者(100%)在OCTA上均有异常。15例患者(88.2%)在脉络膜毛细血管水平检测到一些“信号缺失”点。接受PBR治疗的患者全视网膜平均血管密度显著低于健康受试者(P <.0001)。
接受PBR治疗CM(黄斑区接受全剂量照射)的患者,其视网膜神经纤维层和脉络膜毛细血管均出现主要变化,且脉络膜毛细血管存在血管稀疏。